Skills Lab
Residency, Field Experience, Apprentice
Mobile field lab, data collection.
Residency, Field Experience, Apprentice
Mobile field lab, data collection.
Chemical
Placebo
Cannabinol Pathic Medicine THC / CBD
Purpose utilizing technology, cannabis test kit and diagnostics tool Biopulsar Reflexograph examining impact, strain and dose effectiveness for subject manual documentation.
ABC-IQ Corp. Technologies.
(A) Atomic Are space and time separate?
(t) What is time?
(I) Is time infinite? (t ∞)
What is truth? What is veritas?
(V) Veritas
(E=ME²) What is energy?
Is the current model meeting the learning requirements of all students?
(O9) (ABC-IQ Global Management Systems)
Should people not be given the right to choose cannabis as medicine and be given equal opportunities for treatment options irrespective of leadership, Doctor, Nurse and border for ethical medical treatments?
(Δ9 ) New Frontiers of Cannabinol pathic medicine in Mind Science
Data Set Research Survey
Growth lab beta testing residency tools determining impact effectiveness for specialization and designation slip in suite of ABC-IQ tools. Dispensary diagnostics tools, biotechnologies organ analysis mobile and stationary campus vehicles for assessment and fulfillment for retail client.
ABC-IQ focused on advancing plant-based medicine through dispensary tools, lab development, and integrative health technologies. Operating out of Brandon, Manitoba, we specialize in: online programs of education developing technologies, content and student materials for learning based on empirical and scientific research delivering high quality affordable education through online media for offline application.
Cannabis & Psilocybin Research: Conducting trials on THC, CBD, and synthetic derivatives using Plant check test kits (Pending campus establishment) Security / Entry gate required for medical growth, distribution and testing spaces). Private coastal campus leveraging water supply and 4 seasonal growth for student lab, work experience designation / accommodations. (Funding target 100 acres) or 2 Million CAD 1.7 Million USD Berkus Pre Sales Valuation)
Note level 5 - 7 security clearances and higher security history checks required for student short stay, work experience, residency entry. (At this time, ABC-IQ does not have a campus or retail space for student lead operations) All programs are delivered fully online therefore we do not issue visa certificates or entry letters. Programs are developed for hybrid learning, online offline implementation irrespective of geographical climate and individual certificates are issued online. Pending budgetary requirements, we will expand in person residencies. In the meantime, all programs are accessible for through the abc-iq platform.
$500 000 Rural Vehicle Operations: Lab Development: Building stationary and mobile field growth and branch labs with scan and testing environments for practitioners and residency rotations. Dispensary suite diagnostics tools: Integration: Assessing conditional response using Biopulsar Reflexograph for aura meridian analysis connecting to 40 organs. The practice tool proposes 91% impact effectiveness and aims to triage client to specialist for diagnosis reducing wait times and increasing quality of life.
Regulatory Innovation: Supporting Health Canada compliance with color-coded dosage packaging and long-term effectiveness studies.
Transportation Field lab: recording courses and activities, research and subject supplement for workforce and artificial intelligence adaptation.
Conducting clinical research is a critical step in the generation of good quality evidence needed to better understand the health benefits and harms associated with the potential therapeutic use of psilocybin. Clinical trials are the most appropriate and effective way to advance research with psilocybin while protecting the health and safety of patients and should be the first legal route pursued by individuals seeking access for therapeutic treatment.
Clinical trials protect patients by providing a framework so that a potential treatment is administered in accordance with national and international ethical, medical and scientific standards. They also must be approved by a research ethics board, which provides additional oversight to ensure that patients’ health and safety are protected.
Drugs used in clinical trials must meet Good Manufacturing Practices, the manufacturing standard used in the pharmaceutical industry, to ensure that patients are administered known quantities of quality-controlled active ingredients. This ensures that trial results are representative and reproducible. Clinical trials also benefit society because they help build the evidence related to the safety and efficacy of treatment options for patients.
Health Canada's Clinical Trials Database lists all clinical trials in patients that have been authorized in Canada, including clinical trials involving psilocybin. Individuals wanting to participate in a clinical trial should talk to their health care provider.
Anyone who may wish to conduct a clinical trial in Canada is encouraged to read the Guidance Document for Clinical Trial Sponsors: Clinical Trial Applications for more information on how to apply for a clinical trial authorization.
More information about clinical research with psilocybin can be found in the Notice to Stakeholders - Clarification of Requirements under the Food and Drug Regulations and the Controlled Drugs and Substances Act When Conducting Clinical Research with Psilocybin, which provides details on requirements, information on enforcement and compliance and links to related resources.
Contact abciq@pm.me to get more information on the project